Matrix Metalloproteinase Inhibitors in Cancer Therapy

摘要: Biology and Regulation of the Matrix Metalloproteinases, Mark D. Sternlicht, Lisa M. Coussens, Thiennu H. Vu, Zena Werb. Substrate Specificity MMPs, Hideaki Nagase. The Tissue Inhibitors Metalloproteinases (TIMPs): Regulation, Dylan R. Edwards. in Cancer, Barbara Fingleton Lynn Matrisian. Hydroxamic Acid Metalloproteinase Inhibitors, Peter Brown, Alan Davidson, Drummond, Andrew Gearing, Whittaker. Prinomastat: A Potent Selective Inhibitor-Preclinical Clinical Development for Oncology, David Shalinsky, Bhasker Shetty, Yazdi Pithavala, Steve Bender, Anthony Neri, Stephanie Webber, Krzysztof Appelt, Mary Collier. Nonpeptidic Inhibitor: Discovery BAY 12-9566, George Clemens, Hibner, Rachel Humphrey, Harold Kluender, Scott Wilhelm. D1927 D2163: Novel Mercaptoamide A.D. Baxter, J.B. Bird, Bannister, Bhogal, D.T. Manallack, R.W. Watson, D.A. Owen, J. Montana, Henshilwood, Robert C. Jackson. Research on MMP with Unusual Scaffolds, Frank Grams, Hans Brandstetter, Richard A. Engh, Dagmar Glitz, Hans-Willi Krell, Valeria Livi, Ernesto Menta, Luis Moroder, Constanze Muller, Erich Graf v. Roedern, Gerd Zimmerman. Inhibitors: Therapeutic Applications Outside Michael Niesman. Index.